oru.sePublikationer
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
European Oncology Nursing Society extravasation guidelines
University of Stirling, Department of Midwifery and Nursing, Cancer Care Research Centre, Scotland; Department of Neurobiology, Care science and Society, Division of Nursing, Karolinska Institutet, Stockholm, Sweden.
Department of Oncology, Klinik und Poliklinik für Onkologie, University Hospital Zürich, Rämistrasse 100, Zürich, Switzerland.
2008 (English)In: European Journal of Oncology Nursing, ISSN 1462-3889, E-ISSN 1532-2122, Vol. 12, no 4, 357-361 p.Article in journal (Refereed) Published
Abstract [en]

An infrequent, but potential complication of chemotherapy is vesicant chemotherapy extravasation. Vesicants have the potential to cause blistering and ulceration when they extravasate from the vein or are inadvertently administered into the tissue. In 2007, the European Oncology Nursing Society published guidelines for extravasation prevention, detection, and management. Recommended management includes topical heating for plant alkaloid extravasations and topical cooling for anthracycline and other antitumor antibiotic vesicants. For treatment of antracycline extravasations topical dimethylsulfoxide (DMSO), sodium thiosulfate, and hyaluronidase have been described in the literature but due to lack of evidence to support their use as vesicant extravasation antidotes, it is recommended that these agents are studied further. Furthermore, Savene (R) (dexrazoxane) is the only registered drug for the treatment of antracycline extravasation. Nurses need to be aware of current evidence-based guidelines for detecting and managing vesicant extravasations and need to be prepared to administer evidence-based treatment. (c) 2008 Elsevier Ltd. All rights reserved.

Place, publisher, year, edition, pages
2008. Vol. 12, no 4, 357-361 p.
Keyword [en]
anthracyclines, chemotherapy, complication, extravasation, guidelines, intravenous, patient safety, phlebitis, recall phenomenon, risk factors
National Category
Nursing
Research subject
Nursing Science
Identifiers
URN: urn:nbn:se:oru:diva-36338DOI: 10.1016/j.ejon.2008.07.003ISI: 000259842200010PubMedID: 18765210Scopus ID: 2-s2.0-50549089918OAI: oai:DiVA.org:oru-36338DiVA: diva2:745950
Available from: 2014-09-11 Created: 2014-09-02 Last updated: 2017-10-17Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full textPubMedScopus

Search in DiVA

By author/editor
Wengström, Yvonne
In the same journal
European Journal of Oncology Nursing
Nursing

Search outside of DiVA

GoogleGoogle Scholar

Altmetric score

Total: 21 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf